Click on a filter below to refine your search. Remove a filter to broaden your search.
The risk for severe outcomes of COVID-19 were higher for patients with hematologic versus solid cancer.
Based on the inverse variance weighted method, GERD was found to substantially increase lung cancer risk.
An increase in annual attributable costs was observed over time, from $28,311 in 2007-2013 to $37,055 in 2014-2017.
Immunocompromised patients still can receive convalescent plasma.
A reduction was seen in the rate of one or more opioid days and in the rate of one or more pain-related hospital events.
An increased risk was seen for nonscreenable cancers.
The adjusted predicted probabilities of being aware of alcohol-cancer link were higher for those believing that alcohol increases heart disease risk.
The risk was increased in premenopausal women undergoing oophorectomy for a benign indication before age 43 years.
Cancer survivors who received chemotherapy are more likely to have fracture; the link were stronger within five years of diagnosis.
These preexisting conditions affect functional impairment, mobility and falls.